# A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma

> **NCT01823016** · PHASE2 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 166 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Placebo
- **DRUG:** JNJ-38518168

## Key facts

- **NCT ID:** NCT01823016
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01823016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01823016, "A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01823016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*